Report Detail
Global (United States, European Union and China) Congestive Heart Failure (CHF) Treatment Devices Market Research Report 2019-2025
- RnM3649968 |
- 06 August, 2019 |
- Global |
- 114 Pages |
- QYResearch |
- Other
Congestive heart failure (CHF) is a physiological condition that has an adverse impact on the pumping efficiency of the cardiac muscles. It characterizes the accumulation of fluid around the heart leading to inefficient pumping. The onset of CHF is marked by the failure of the ventricles to pump sufficient volume of blood to the body organs. This eventually leads to deposition of fluid in the lungs, abdomen, liver, and lower body. CHF is treated by a number of devices that maintain heart rhythm, such as pacemakers, cardiac resynchronization therapy (CRT), implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs).
This is primarily attributed to the constantly changing lifestyle habits (such as unhealthy dietary habits, excessive alcohol consumption, smoking, obesity, and lack of physical activity) which make individuals more susceptible to arrhythmia and heart failure. In addition, a number of factors such as the large number of technological advancements in CHF treatment devices, increased adoption rate of these devices, and rising emphasis on early intervention and primary prevention of heart-related disorders are responsible for driving the market. Conversely, stringent government regulations for the approval of CHF treatment devices, high cost of, and high preference to drugs for CHF treatment are some of the factors restraining the market growth.
In 2019, the market size of Congestive Heart Failure (CHF) Treatment Devices is 11000 million US$ and it will reach 17200 million US$ in 2025, growing at a CAGR of 5.7% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Congestive Heart Failure (CHF) Treatment Devices.
This report studies the global market size of Congestive Heart Failure (CHF) Treatment Devices, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Congestive Heart Failure (CHF) Treatment Devices production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Abiomed
Berlin Heart GmbH
Biotronik SE & Co. KG
Boston Scientific Corporation
HeartWare International
Jarvik Heart
LivaNova PLC
Medtronic
ReliantHeart
St. Jude Medical
Market Segment by Product Type
Cardiac Resynchronization Therapy (CRT)
Implantable Cardioverter Defibrillators (ICDs)
Market Segment by Application
Left Ventricular Assist Device (LVAD)
Right Ventricular Assist Device (RVAD)
Biventricular Assist Device (BIVAD)
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Congestive Heart Failure (CHF) Treatment Devices status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Congestive Heart Failure (CHF) Treatment Devices manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Congestive Heart Failure (CHF) Treatment Devices are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Research Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Cardiac Resynchronization Therapy (CRT)
- 1.3.3 Implantable Cardioverter Defibrillators (ICDs)
- 1.4 Market Segment by Application
- 1.4.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Share by Application (2019-2025)
- 1.4.2 Left Ventricular Assist Device (LVAD)
- 1.4.3 Right Ventricular Assist Device (RVAD)
- 1.4.4 Biventricular Assist Device (BIVAD)
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Production and Capacity Analysis
- 2.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Production Value 2014-2025
- 2.1.2 Global Congestive Heart Failure (CHF) Treatment Devices Production 2014-2025
- 2.1.3 Global Congestive Heart Failure (CHF) Treatment Devices Capacity 2014-2025
- 2.1.4 Global Congestive Heart Failure (CHF) Treatment Devices Marketing Pricing and Trends
- 2.2 Key Producers Growth Rate (CAGR) 2019-2025
- 2.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Size CAGR of Key Regions
- 2.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Market Share of Key Regions
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Capacity and Production by Manufacturers
- 3.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Capacity by Manufacturers
- 3.1.2 Global Congestive Heart Failure (CHF) Treatment Devices Production by Manufacturers
- 3.2 Revenue by Manufacturers
- 3.2.1 Congestive Heart Failure (CHF) Treatment Devices Revenue by Manufacturers (2014-2019)
- 3.2.2 Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Congestive Heart Failure (CHF) Treatment Devices Market Concentration Ratio (CR5 and HHI)
- 3.3 Congestive Heart Failure (CHF) Treatment Devices Price by Manufacturers
- 3.4 Key Manufacturers Congestive Heart Failure (CHF) Treatment Devices Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Congestive Heart Failure (CHF) Treatment Devices Market
- 3.6 Key Manufacturers Congestive Heart Failure (CHF) Treatment Devices Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Production and Production Value for Each Type
- 4.1.1 Cardiac Resynchronization Therapy (CRT) Production and Production Value (2014-2019)
- 4.1.2 Implantable Cardioverter Defibrillators (ICDs) Production and Production Value (2014-2019)
- 4.2 Global Congestive Heart Failure (CHF) Treatment Devices Production Market Share by Type
- 4.3 Global Congestive Heart Failure (CHF) Treatment Devices Production Value Market Share by Type
- 4.4 Congestive Heart Failure (CHF) Treatment Devices Ex-factory Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Congestive Heart Failure (CHF) Treatment Devices Consumption by Application
6 Production by Regions
- 6.1 Global Congestive Heart Failure (CHF) Treatment Devices Production (History Data) by Regions 2014-2019
- 6.2 Global Congestive Heart Failure (CHF) Treatment Devices Production Value (History Data) by Regions
- 6.3 United States
- 6.3.1 United States Congestive Heart Failure (CHF) Treatment Devices Production Growth Rate 2014-2019
- 6.3.2 United States Congestive Heart Failure (CHF) Treatment Devices Production Value Growth Rate 2014-2019
- 6.3.3 Key Players in United States
- 6.3.4 United States Congestive Heart Failure (CHF) Treatment Devices Import & Export
- 6.4 European Union
- 6.4.1 European Union Congestive Heart Failure (CHF) Treatment Devices Production Growth Rate 2014-2019
- 6.4.2 European Union Congestive Heart Failure (CHF) Treatment Devices Production Value Growth Rate 2014-2019
- 6.4.3 Key Players in European Union
- 6.4.4 European Union Congestive Heart Failure (CHF) Treatment Devices Import & Export
- 6.5 China
- 6.5.1 China Congestive Heart Failure (CHF) Treatment Devices Production Growth Rate 2014-2019
- 6.5.2 China Congestive Heart Failure (CHF) Treatment Devices Production Value Growth Rate 2014-2019
- 6.5.3 Key Players in China
- 6.5.4 China Congestive Heart Failure (CHF) Treatment Devices Import & Export
- 6.6 Rest of World
- 6.6.1 Japan
- 6.6.2 Korea
- 6.6.3 India
- 6.6.4 Southeast Asia
7 Congestive Heart Failure (CHF) Treatment Devices Consumption by Regions
- 7.1 Global Congestive Heart Failure (CHF) Treatment Devices Consumption (History Data) by Regions
- 7.2 United States
- 7.2.1 United States Congestive Heart Failure (CHF) Treatment Devices Consumption by Type
- 7.2.2 United States Congestive Heart Failure (CHF) Treatment Devices Consumption by Application
- 7.3 European Union
- 7.3.1 European Union Congestive Heart Failure (CHF) Treatment Devices Consumption by Type
- 7.3.2 European Union Congestive Heart Failure (CHF) Treatment Devices Consumption by Application
- 7.4 China
- 7.4.1 China Congestive Heart Failure (CHF) Treatment Devices Consumption by Type
- 7.4.2 China Congestive Heart Failure (CHF) Treatment Devices Consumption by Application
- 7.5 Rest of World
- 7.5.1 Rest of World Congestive Heart Failure (CHF) Treatment Devices Consumption by Type
- 7.5.2 Rest of World Congestive Heart Failure (CHF) Treatment Devices Consumption by Application
- 7.5.1 Japan
- 7.5.2 Korea
- 7.5.3 India
- 7.5.4 Southeast Asia
8 Company Profiles
- 8.1 Abiomed
- 8.1.1 Abiomed Company Details
- 8.1.2 Company Description and Business Overview
- 8.1.3 Production and Revenue of Congestive Heart Failure (CHF) Treatment Devices
- 8.1.4 Congestive Heart Failure (CHF) Treatment Devices Product Introduction
- 8.1.5 Abiomed Recent Development
- 8.2 Berlin Heart GmbH
- 8.2.1 Berlin Heart GmbH Company Details
- 8.2.2 Company Description and Business Overview
- 8.2.3 Production and Revenue of Congestive Heart Failure (CHF) Treatment Devices
- 8.2.4 Congestive Heart Failure (CHF) Treatment Devices Product Introduction
- 8.2.5 Berlin Heart GmbH Recent Development
- 8.3 Biotronik SE & Co. KG
- 8.3.1 Biotronik SE & Co. KG Company Details
- 8.3.2 Company Description and Business Overview
- 8.3.3 Production and Revenue of Congestive Heart Failure (CHF) Treatment Devices
- 8.3.4 Congestive Heart Failure (CHF) Treatment Devices Product Introduction
- 8.3.5 Biotronik SE & Co. KG Recent Development
- 8.4 Boston Scientific Corporation
- 8.4.1 Boston Scientific Corporation Company Details
- 8.4.2 Company Description and Business Overview
- 8.4.3 Production and Revenue of Congestive Heart Failure (CHF) Treatment Devices
- 8.4.4 Congestive Heart Failure (CHF) Treatment Devices Product Introduction
- 8.4.5 Boston Scientific Corporation Recent Development
- 8.5 HeartWare International
- 8.5.1 HeartWare International Company Details
- 8.5.2 Company Description and Business Overview
- 8.5.3 Production and Revenue of Congestive Heart Failure (CHF) Treatment Devices
- 8.5.4 Congestive Heart Failure (CHF) Treatment Devices Product Introduction
- 8.5.5 HeartWare International Recent Development
- 8.6 Jarvik Heart
- 8.6.1 Jarvik Heart Company Details
- 8.6.2 Company Description and Business Overview
- 8.6.3 Production and Revenue of Congestive Heart Failure (CHF) Treatment Devices
- 8.6.4 Congestive Heart Failure (CHF) Treatment Devices Product Introduction
- 8.6.5 Jarvik Heart Recent Development
- 8.7 LivaNova PLC
- 8.7.1 LivaNova PLC Company Details
- 8.7.2 Company Description and Business Overview
- 8.7.3 Production and Revenue of Congestive Heart Failure (CHF) Treatment Devices
- 8.7.4 Congestive Heart Failure (CHF) Treatment Devices Product Introduction
- 8.7.5 LivaNova PLC Recent Development
- 8.8 Medtronic
- 8.8.1 Medtronic Company Details
- 8.8.2 Company Description and Business Overview
- 8.8.3 Production and Revenue of Congestive Heart Failure (CHF) Treatment Devices
- 8.8.4 Congestive Heart Failure (CHF) Treatment Devices Product Introduction
- 8.8.5 Medtronic Recent Development
- 8.9 ReliantHeart
- 8.9.1 ReliantHeart Company Details
- 8.9.2 Company Description and Business Overview
- 8.9.3 Production and Revenue of Congestive Heart Failure (CHF) Treatment Devices
- 8.9.4 Congestive Heart Failure (CHF) Treatment Devices Product Introduction
- 8.9.5 ReliantHeart Recent Development
- 8.10 St. Jude Medical
- 8.10.1 St. Jude Medical Company Details
- 8.10.2 Company Description and Business Overview
- 8.10.3 Production and Revenue of Congestive Heart Failure (CHF) Treatment Devices
- 8.10.4 Congestive Heart Failure (CHF) Treatment Devices Product Introduction
- 8.10.5 St. Jude Medical Recent Development
9 Market Forecast
- 9.1 Global Market Size Forecast
- 9.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Capacity, Production Forecast 2019-2025
- 9.1.2 Global Congestive Heart Failure (CHF) Treatment Devices Production Value Forecast 2019-2025
- 9.2 Market Forecast by Regions
- 9.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Production and Value Forecast by Regions 2019-2025
- 9.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Consumption Forecast by Regions 2019-2025
- 9.3 United States
- 9.3.1 Production and Value Forecast in United States
- 9.3.2 Consumption Forecast in United States
- 9.4 European Union
- 9.4.1 Production and Value Forecast in European Union
- 9.4.2 Consumption Forecast in European Union
- 9.5 China
- 9.5.1 Production and Value Forecast in China
- 9.5.2 Consumption Forecast in China
- 9.6 Rest of World
- 9.6.1 Japan
- 9.6.2 Korea
- 9.6.3 India
- 9.6.4 Southeast Asia
- 9.7 Forecast by Type
- 9.7.1 Global Congestive Heart Failure (CHF) Treatment Devices Production Forecast by Type
- 9.7.2 Global Congestive Heart Failure (CHF) Treatment Devices Production Value Forecast by Type
- 9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
- 10.1 Value Chain Analysis
- 10.2 Sales Channels Analysis
- 10.2.1 Congestive Heart Failure (CHF) Treatment Devices Sales Channels
- 10.2.2 Congestive Heart Failure (CHF) Treatment Devices Distributors
- 10.3 Congestive Heart Failure (CHF) Treatment Devices Customers
11 Opportunities & Challenges, Threat and Affecting Factors
- 11.1 Market Opportunities
- 11.2 Market Challenges
- 11.3 Porter's Five Forces Analysis
12 Key Findings
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.1.1 Research Programs/Design
- 13.1.1.2 Market Size Estimation
- 13.1.1.3 Market Breakdown and Data Triangulation
- 13.1.2 Data Source
- 13.1.2.1 Secondary Sources
- 13.1.2.2 Primary Sources
- 13.1.1 Methodology/Research Approach
- 13.2 Author Details
Summary:
Get latest Market Research Reports on Congestive Heart Failure (CHF) Treatment Devices. Industry analysis & Market Report on Congestive Heart Failure (CHF) Treatment Devices is a syndicated market report, published as Global (United States, European Union and China) Congestive Heart Failure (CHF) Treatment Devices Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Congestive Heart Failure (CHF) Treatment Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
